• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cala Health announces new chief commercial, financial officers amid leadership expansion

Cala Health announces new chief commercial, financial officers amid leadership expansion

March 28, 2022 By Sean Whooley

Cala HealthCala Health announced today that it has expanded its leadership team with a number of appointments, including new chief commercial and financial officers.

New executives joining the company — which develops bioelectronic medicines to provide new therapies for chronic diseases — hold experience from major players in the medtech space, including iRhythm, Johnson & Johnson, Boston Scientific, Medtronic, Google and more.

The company also announced a new, larger headquarters in San Mateo, California. Cala designed the LEED-certified building to support its growth as a flexible workspace with a high-functioning manufacturing and fulfillment center.

Joining Cala as chief commercial officer (CCO) is Doug Biehn, who most recently served as EVP of marketing at iRhythm. He was also COO at AliveCor and chief marketing officer at Blue Shield of California.

“I’m excited to be part of such an innovative and patient-centric company that is freeing people from the burden of chronic disease, especially during this period of accelerated growth,” Biehn said in the release. “Cala’s team is dedicated to building a world-class commercial organization that makes it easier for patients to access the life-changing Cala therapy and helps physicians and neurology practices raise the standard of care on how they treat essential tremor.”

Tim Gallagher has been named CFO at Cala, having spent time in Amazon’s Lab126 hardware division and Google. He most recently served as CFO at an unnamed startup in London that produces electronic keyboards.

“As CFO, my priority will be to focus commercial resources to maximize sales and marketing productivity, and ultimately build a predictable, repeatable, and scalable go-to-market model to establish Cala as the new standard of care,” Gallagher said.

Other appointments include Jeron Evans as VP of sales, Deanna Harshbarger as VP of product and medical affairs, and Bernard Shay as general counsel.

Evans previously served as VP and global head of the psoriasis franchise at UCB BioPharma. Harshbarger joins having spent 18 years in medtech, including positions at Medtronic, Boston Scientific and Johnson & Johnson. Shay, a senior medical device attorney, previously worked at GE, IBM, Johnson & Johnson, Miramar Labs and Earlens Corp.

Filed Under: Bioelectronic Medicine, Business/Financial News, Digital Health, Featured, Health Technology, Neurological, Neuromodulation/Neurostimulation, Software / IT Tagged With: Cala Health, Personnel Moves

More recent news

  • Medtronic reports first patient treated in study of multi-organ denervation for hypertension
  • Baxter turns to an automation company for its new CEO
  • Pristine Surgical appoints new CFO
  • Boston Scientific wins expanded FDA nod for Farapulse PFA
  • FDA warns on issue with J&J Abiomed pump controllers related to 3 deaths

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy